Keywords: positive, ph, iii, data, schering-plough, noxafil, reported

Positive Ph III data for Schering-Plough's Noxafil

Article | 04 August 2003

Schering-Plough has reported that a Phase III trial, examining its Noxafil (posaconazole suspension) in 337 patients with invasive fungal infections, has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Schering Plough

Schering-Plough

Go to company listing

Related Drugs

Noxafil

Posaconazole Oral Suspension

Go to drug listing